| Abbreviation | Meaning |
|---|---|
| AKAP | A-kinase anchor protein |
| AKAP13 | A-kinase anchor protein 13 |
| ALA | α-lipoic acid |
| ATP | adenosine triphosphate |
| BGT | betaine gamma aminobutyric acid transporter |
| BMD | Becker muscular dystrophy |
| CBP | CREB binding protein |
| COX | cyclooxygenase |
| CRF | corticotropin-releasing factor |
| CXCL | chemokine ligand |
| DAG | diacylglycerol |
| DAPC | dystrophin-associated protein complex |
| DMD | Duchenne muscular dystrophy |
| FDA | Food and Drug Administration |
| GABA | gamma aminobutyric acid |
| GCs | glucocorticoids |
| GLUT4 | glucose transporter type 4 |
| GR | glucocorticoid receptor |
| GSK-3 | glycogen synthase kinase 3 |
| GSK-3β | glycogen synthase kinase 3 beta |
| GTP | guanosinetrifosfaat |
| HNE | 4-hydroxynonenal |
| Hsp70 | heat shock protein 70 |
| ICAM-1 | intracellular adhesion molecule 1 |
| IL | interleukine |
| IP3 | inositol triphosphate |
| L-CAR | L-carnitine |
| MAPK | mitogen-activated protein kinase |
| MI | myo-inositol |
| NFAT | nuclear factor of activated T- cells |
| NFAT5 | nuclear factor of activated T- cells 5 |
| NFAT5c | nuclear factor of activated T- cells c |
| NF-ƘB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| nNOS | neuronal nitric oxide synthase |
| PKA | protein kinase A |
| PKC | protein kinase C |
| p-p38 | phosphorylated p38 |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate |
| Rac 1 | Ras-related C3 botulinum toxin substrate |
| s.c. | subcutaneous |
| SCID | severe combined immunodeficiency |
| SMIT | sodium myo-inositol transporter |
| SRC-1 | steroid receptor coactivator 1 |
| TauT | Taurine transporter |
| TBP | TATA box binding protein |
| TGF-β | transforming growth factor-β |
| TNF-α | tumor necrosis factor α |
| TonEBP | Tonicity-responsive enhancer binding protein |
| Ucns | urocortins |
| VCAM-1 | vascular cell adhesion molecule 1 |
| VSMC | vascular smooth muscle cells |
| xIL-6R | anti-interleukin-6 receptor antibody |